Escitalopram Treatment of Patients With Agitated Dementia
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of escitalopram (Lexapro)
using 10 or 20 mg daily in patients with Alzheimer's disease who are also experiencing
agitation.